# US 2023/0264035 A1 · Cardiac electrical signal morphology and pattern-based t-wave oversensing rejection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0264035 A1
- Document ID: US20230264035A1
- Status: Published application
- Kind: A1
- Application number: 18/311,861
- Filed: 2023-05-03
- Published: 2023-08-24
- Earliest claimed: 2016-07-27
- Assignees: Medtronic, Inc.
- Applicants: Medtronic, Inc.
- Inventors: Jian CAO; Saul E. GREENHUT; Xusheng ZHANG
- Web page: https://patentgrep.com/patent/US20230264035A1

## CPC

- A61N 1/3956: {Implantable devices for applying electric shocks to the heart, e.g. for cardioversion}
- A61B 5/29: for permanent or long-term implantation
- A61B 5/33: specially adapted for cooperation with other devices
- A61B 5/341: Vectorcardiography [VCG]
- A61B 5/35: by template matching
- A61B 5/352: Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
- A61B 5/355: Detecting T-waves
- A61B 5/363: Detecting tachycardia or bradycardia
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/686: {Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence)}
- A61B 5/7221: {Determining signal validity, reliability or quality (preventing, reducing or removing noise induced by motion artefacts A61B5/7207; noise originating from a therapeutic or surgical apparatus A61B5/7217)}
- A61N 1/3621: {for treating or preventing abnormally high heart rate}
- A61N 1/3704: {Circuits specially adapted therefor, e.g. for sensitivity control}
- A61N 1/3925: {Monitoring; Protecting}
- A61N 1/3987: {characterised by the timing or triggering of the shock}
- A61B 5/364: Detecting abnormal ECG interval, e.g. extrasystoles, ectopic heartbeats
- A61N 1/39622: {Pacing therapy}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A medical device, such as an extra-cardiovascular implantable cardioverter defibrillator (ICD), senses R-waves from a first cardiac electrical signal by a first sensing channel and stores a time segment of a second cardiac electrical signal acquired by a second sensing channel in response to each sensed R-wave. The ICD determines morphology match scores from the stored time segments of the second cardiac electrical signal and, based on the morphology match scores, withholds detection of a tachyarrhythmia episode. In some examples, the ICD detects T-wave oversensing based on the morphology match scores and withholds detection of a tachyarrhythmia episode in response to detecting the T-wave oversensing.

## Claims

### Claim 1

A medical device comprising:
a sensing circuit configured to:
sense a first cardiac electrical signal and a second cardiac electrical signal;
produce an R-wave sensed event signal in response to the first cardiac electrical signal crossing an R-wave sensing threshold;
a control circuit configured to:
identify a first group of n R-wave sensed event signals produced by the sensing circuit;
analyze the first cardiac electrical signal for determining if the first group of n R-wave sensed event signals meet first T-wave oversensing criteria;
analyze at least the second cardiac electrical signal for determining if the first group of n R-wave sensed event signals meet second T-wave oversensing criteria;
determine that at least one of the first T-wave oversensing criteria or the second T-wave oversensing criteria are met for the first group of n R-wave sensed event signals;
detect T-wave oversensing in the first group of n R-wave sensed event signals in response to at least one of the first T-wave oversensing criteria being met or the second T-wave oversensing criteria being met for the first group of n R-wave sensed event signals;
determine that a threshold number of tachyarrhythmia detection intervals is reached for detecting a tachyarrhythmia based on the R-wave sensed event signals produced by the sensing circuit; and
in response to detecting the T-wave oversensing in at least the group of n R-wave sensed event signals, withhold detecting the tachyarrhythmia when the threshold number of tachyarrhythmia detection intervals is reached.

### Claim 2 (depends on 1)

The medical device of claim 1 wherein the control circuit is further configured to:
identify a plurality of groups of n R-wave sensed event signals produced by the sensing circuit, the plurality of groups of n R-wave sensed event signals including at least the first group of n R-wave sensed event signals;
for each respective group of n R-wave sensed event signals of the identified plurality of groups of n R-wave sensed event signals:
analyze the first cardiac electrical signal for determining if the respective group of n R-wave sensed event signals meets the first T-wave oversensing criteria;
analyze at least the second cardiac electrical signal for determining if the respective group of n R-wave sensed event signals meets second T-wave oversensing criteria;
detect T-wave oversensing in the respective group of n R-wave sensed event signals in response to at least one of the first T-wave oversensing criteria or the second T-wave oversensing being met;
determine that T-wave oversensing is detected in at least a first threshold number of the plurality of groups of n R-wave sensed event signals; and
in response to at least detecting the T-wave oversensing in at least the first threshold number of the plurality of groups of n R-wave sensed event signals, withhold detecting the tachyarrhythmia when the threshold number of tachyarrhythmia detection intervals is reached.

### Claim 3 (depends on 2)

The medical device of claim 2 wherein the control circuit is further configured to:
determine that T-wave oversensing is detected in at least a second threshold number of a most recent portion of the plurality of groups of n R-wave sensed event signals; and
withhold detecting the tachyarrhythmia in response to determining that:
a) T-wave oversensing is detected in at least the first threshold number of the plurality of groups of n R-wave sensed event signals; and
b) T-wave oversensing is detected in at least the second threshold number of the most recent portion of the plurality of groups of n R-wave sensed event signals.

### Claim 4 (depends on 2)

The medical device of claim 2 wherein the plurality of groups of n R-wave sensed event signals comprise overlapping groups of n R-wave sensed event signals.

### Claim 5 (depends on 1)

The medical device of claim 1 wherein the control circuit is further configured to:
identify a second group of n R-wave sensed event signals produced by the sensing circuit;
determine that the first T-wave oversensing criteria and the second T-wave sensing criteria are not met by the second group of n R-wave sensed event signals; and
detect the tachyarrhythmia in response to at least the second group of n R-wave sensed event signals not meeting the first T-wave oversensing criteria and not meeting the second T-wave oversensing criteria; and
the medical device further comprising a therapy delivery circuit configured to deliver an anti-tachyarrhythmia therapy in response to the control circuit detecting the tachyarrhythmia.

### Claim 6 (depends on 1)

The medical device of claim 1 wherein the control circuit is further configured to analyze at least the second cardiac electrical signal for determining if the first group of n R-wave sensed event signals meet the second T-wave oversensing criteria by:
determining morphology matching scores from the second cardiac electrical signal for the first group of n R-wave sensed event signals;
determining maximum peak amplitudes from the first cardiac electrical signal for the first group of n R-wave sensed event signals; and
determining if the first group of n R-wave sensed event signals meet the second T-wave oversensing criteria based on the morphology match scores and the maximum peak amplitudes.

### Claim 7 (depends on 1)

The medical device of claim 1 wherein the control circuit is further configured to analyze at least the second cardiac electrical signal for determining if the first group of n R-wave sensed event signals meet the second T-wave oversensing criteria by:
determining a morphology match score from the second cardiac signal for each R-wave sensed event signal of the first group of n R-wave sensed event signals;
detect at least one R-wave and T-wave pair based on the morphology match scores; and
determine that the second T-wave oversensing criteria are met based on detecting the at least one R-wave and T-wave pair.

### Claim 8 (depends on 7)

The medical device of claim 7 wherein the control circuit is further configured to:
compare a first morphology match score of the determined morphology match scores to a first morphology match threshold;
compare a second morphology match score of the determined morphology match scores to a second morphology match threshold different than the first morphology match threshold; and
detect the at least one R-wave and T-wave pair based on at least the first morphology match score being greater than the first morphology match threshold and the second morphology match score being less than the second morphology match threshold.

### Claim 9 (depends on 8)

The medical device of claim 8 wherein the control circuit is further configured to:
determine a differential signal from the first cardiac electrical signal; and
detect the at least one R-wave and T-wave pair when a first amplitude of the differential signal associated with the R-wave and T-wave pair is less than a threshold percentage of a second amplitude of the differential signal associated with the R-wave and T-wave pair.

### Claim 10 (depends on 1)

The medical device of claim 1 wherein the control circuit is further configured to analyze the first cardiac electrical signal for determining if the group of n R-wave sensed event signals meet first T-wave oversensing criteria by:
identifying a highest peak amplitude from each of multiple pairs of the first group of n R-wave sensed event signals;
determining an amplitude threshold from the identified highest peak amplitudes;
classifying each R-wave sensed event signal of the group of n R-wave sensed event signals as either an R-wave or a T-wave based on whether the first cardiac electrical signal crosses the determined amplitude threshold at a time corresponding to a respective R-wave sensed event signal of the group of n R-wave sensed event signals;
determining that at least a threshold number of the classified R-wave sensed event signals are classified as T-waves; and
determining that the R-wave sensed event signals that are classified as T-waves alternate with R-wave sensed event signals that are classified as R-waves.

### Claim 11 (depends on 1)

The medical device of claim 1 further comprising a therapy delivery circuit configured to deliver an anti-tachyarrhythmia therapy in response to the control circuit detecting tachyarrhythmia.

### Claim 12

A method comprising:
sensing a first cardiac electrical signal and a second cardiac electrical signal;
producing an R-wave sensed event signal in response to the first cardiac electrical signal crossing an R-wave sensing threshold;
identifying a first group of n R-wave sensed event signals produced by the sensing circuit;
analyzing the first cardiac electrical signal for determining if the first group of n R-wave sensed event signals meet first T-wave oversensing criteria;
analyzing at least the second cardiac electrical signal for determining if the first group of n R-wave sensed event signals meets second T-wave oversensing criteria;
determining whether at least one of the first T-wave oversensing criteria or the second T-wave oversensing criteria are met for the first group of n R-wave sensed event signals;
determining that a threshold number of tachyarrhythmia detection intervals is reached for detecting a tachyarrhythmia based on the R-wave sensed event signals produced by the sensing circuit;
withholding detecting the tachyarrhythmia when the threshold number of tachyarrhythmia detection intervals is reached and at least one of the first T-wave oversensing criteria or the second T-wave oversensing criteria are determined to be met for at least the first group of n R-wave sensed event signals;
detecting the tachyarrhythmia when the threshold number of tachyarrhythmia detection intervals is reached and neither the first T-wave oversensing criteria or the second T-wave oversensing criteria are determined to be met for the first group of n R-wave sensed event signals; and
delivering an anti-tachyarrhythmia therapy in response to detecting tachyarrhythmia.

### Claim 13 (depends on 12)

The method of claim 12 further comprising:
identifying a plurality of groups of n R-wave sensed event signals produced by the sensing circuit, the plurality of groups of n R-wave sensed event signals including at least the first group of n R-wave sensed event signals;
for each respective group of n R-wave sensed event signals of the identified plurality of groups of n R-wave sensed event signals:
analyzing the first cardiac electrical signal for determining if the respective group of n R-wave sensed event signals meets the first T-wave oversensing criteria;
analyzing at least the second cardiac electrical signal for determining if the respective group of n R-wave sensed event signals meets second T-wave oversensing criteria;
detecting T-wave oversensing in the respective group of n R-wave sensed event signals in response to at least one of the first T-wave oversensing criteria or the second T-wave oversensing being met;
determining that T-wave oversensing is detected in at least a first threshold number of the plurality of groups of n R-wave sensed event signals; and
withholding detecting the tachyarrhythmia when the threshold number of tachyarrhythmia detection intervals is reached and T-wave oversensing is detected in at least the first threshold number of the plurality of groups of n R-wave sensed event signals.

### Claim 14 (depends on 13)

The method of claim 13 further comprising:
determining that T-wave oversensing is detected in at least a second threshold number of a most recent portion of the plurality of groups of n R-wave sensed event signals; and
withholding detecting the tachyarrhythmia in response to determining that:
a) T-wave oversensing is detected in at least the first threshold number of the plurality of groups of n R-wave sensed event signals; and
b) T-wave oversensing is detected in at least the second threshold number of the most recent portion of the plurality of groups of n R-wave sensed event signals.

### Claim 15 (depends on 13)

The method of claim 13 wherein the plurality of groups of n R-wave sensed event signals comprise overlapping groups of n R-wave sensed event signals.

### Claim 16 (depends on 12)

The method of claim 12 further comprising, when detecting the tachyarrhythmia is withheld:
identifying a second group of n R-wave sensed event signals produced by the sensing circuit;
determining that the first T-wave oversensing criteria and the second T-wave sensing criteria are not met by the second group of n R-wave sensed event signals; and
detecting the tachyarrhythmia in response to at least the second group of n R-wave sensed event signals not meeting the first T-wave oversensing criteria and not meeting the second T-wave oversensing criteria.

### Claim 17 (depends on 12)

The method of claim 12 wherein analyzing at least the second cardiac electrical signal for determining if the first group of n R-wave sensed event signals meet the second T-wave oversensing criteria comprises:
determining morphology match scores from the second cardiac electrical signal for the first group of n R-wave sensed event signals;
determining maximum peak amplitudes from the first cardiac electrical signal for the first group of n R-wave sensed event signals; and
determining if the first group of n R-wave sensed event signals meet the second T-wave oversensing criteria based on the morphology match scores and the maximum peak amplitudes.

### Claim 18 (depends on 12)

The method of claim 12 wherein analyzing at least the second cardiac electrical signal for determining if the first group of n R-wave sensed event signals meet the second T-wave oversensing criteria comprises:
determining a morphology match score from the second cardiac signal for each R-wave sensed event signal of the first group of n R-wave sensed event signals;
detecting at least one R-wave and T-wave pair based on the morphology match scores; and
determine that the second T-wave oversensing criteria are met based on detecting the at least one R-wave and T-wave pair.

### Claim 19 (depends on 18)

The method of claim 18 further comprising:
comparing a first morphology match score of the determined morphology match scores to a first morphology match threshold;
comparing a second morphology match score of the determined morphology match scores to a second morphology match threshold different than the first morphology match threshold; and
detecting the at least one R-wave and T-wave pair based on at least the first morphology match score being greater than the first morphology match threshold and the second morphology match score being less than the second morphology match threshold.

### Claim 20 (depends on 19)

The method of claim 19 further comprising:
determining a differential signal from the first cardiac electrical signal; and
detecting the at least one R-wave and T-wave pair when a first amplitude of the differential signal associated with the R-wave and T-wave pair is less than a threshold percentage of a second amplitude of the differential signal associated with the R-wave and T-wave pair.

### Claim 21 (depends on 12)

The method of claim 12 wherein analyzing the first cardiac electrical signal for determining if the group of n R-wave sensed event signals meet first T-wave oversensing criteria comprises:
identifying a highest peak amplitude from each of multiple pairs of the first group of n R-wave sensed event signals;
determining an amplitude threshold from the identified highest peak amplitudes;
classifying each R-wave sensed event signal of the group of n R-wave sensed event signals as either an R-wave or a T-wave based on whether the first cardiac electrical signal crosses the determined amplitude threshold at a time corresponding to a respective R-wave sensed event signal of the group of n R-wave sensed event signals;
determining that at least a threshold number of the classified R-wave sensed event signals are classified as T-waves; and
determining that the R-wave sensed event signals that are classified as T-waves alternate with R-wave sensed event signals that are classified as R-waves.

### Claim 22

A non-transitory, computer-readable storage medium comprising a set of instructions which, when executed by a control circuit of a medical device, cause the device to:
sense a first cardiac electrical signal and a second cardiac electrical signal;
produce an R-wave sensed event signal in response to the first cardiac electrical signal crossing an R-wave sensing threshold;
identify a group of n R-wave sensed event signals produced by the sensing circuit;
analyze the first cardiac electrical signal for determining if the group of n R-wave sensed event signals meet first T-wave oversensing criteria;
analyze at least the second cardiac electrical signal for determining if the group of n R-wave sensed event signals meet second T-wave oversensing criteria;
determine whether T-wave oversensing is detected in the group of n R-wave sensed event signals based on whether at least one of the first T-wave oversensing criteria is met or the second T-wave oversensing criteria is met for the group of n R-wave sensed event signals;
determine that a threshold number of tachyarrhythmia detection intervals is reached for detecting a tachyarrhythmia based on the R-wave sensed event signals produced by the sensing circuit;
withhold detecting the tachyarrhythmia when the threshold number of tachyarrhythmia detection intervals is reached and T-wave oversensing is detected; and
deliver an anti-tachyarrhythmia therapy when the threshold number of tachyarrhythmia detection intervals is reached and T-wave oversensing is not detected.
